After-hours 19:00 (ET)ADCT Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-0.11
Revenue Actual (USD)19.25M
ADC Therapeutics SA Earnings Dates & Reports
This page offers detailed ADC Therapeutics SA earnings data including the latest ADC Therapeutics SA earnings report, the upcoming ADC Therapeutics SA earnings date, historical data and ADC Therapeutics SA earnings call news.
ADCT Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
ADCT FY2025 Earnings
EPS (YoY)-1.1230.91%
Revenue (YoY)81.36M14.85%
ADC Therapeutics SA (ADCT) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.11/-0.21 | 19.25M/19.38M | 49.59% | -0.66% |
| 5/4/2026 | 03/2026 | -0.21/-0.21 | 20.85M/19.24M | 0.52% | 8.37% |
| 3/10/2026 | 12/2025 | -0.04/-0.27 | 23.06M/21.39M | 84.14% | 7.80% |
| 11/10/2025 | 09/2025 | -0.36/-0.36 | 16.43M/17.08M | -0.57% | -3.81% |
| 8/12/2025 | 06/2025 | -0.50/-0.47 | 18.84M/17.86M | -5.07% | 5.48% |
| 5/14/2025 | 03/2025 | -0.36/-0.40 | 23.03M/17.71M | 10.72% | 30.07% |
| 3/27/2025 | 12/2024 | -0.29/-0.41 | 16.91M/19.01M | 29.22% | -11.03% |
| 11/7/2024 | 09/2024 | -0.42/-0.40 | 18.46M/18.46M | -6.19% | 0.01% |
ADC Therapeutics SA Latest Earnings Call Transcripts
ADC Therapeutics (ADCT) Q2 2026 Earnings Call: LOTIS-5 FDA Concerns, $219.1M Cash
ADC Therapeutics Q2 2026 earnings call: ZYNLONTA revenue reached $18.6 million, while FDA concerns clouded the LOTIS-5 regulatory path.